Merck's Q3 Results, Guidance Look Strong

Merck & Co., Inc. MRK delivered better than expected results for the third quarter. The company also updated its full year outlook, sending the stock higher in pre-market trading.

• Merck reported GAAP EPS of $0.78 and adjusted EPS of $1.07 and beat consensus by $0.08 a share.
• Generated $10.5 billion sales revenue and topped Street estimates by $0.356 billion.
• Narrowed and lifted full year EPS outlook to $2.02-$2.09 and adjusted EPS between $3.71 and $3.78.
• Similarly, revenue forecast has been narrowed and increased to $39.7-$40.2 billion.
• Street is looking for an EPS of $3.75 on revenue of $39.70 billion for the year 2016.

The stock gained 2.22 percent to $62.10 in pre-market trading.